(1->4)-beta-D-glucan multiple interactions ISO Slc19a1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC19A1 mRNA CTD PMID:36331819 (S)-nicotine decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Nicotine results in decreased expression of SLC19A1 mRNA CTD PMID:19616087 1,2-dichloroethane decreases expression ISO Slc19a1 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of SLC19A1 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO Slc19a1 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SLC19A1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO Slc19a1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC19A1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of SLC19A1 mRNA CTD PMID:17108234 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of SLC19A1 mRNA CTD PMID:16079270 17alpha-ethynylestradiol increases expression ISO Slc19a1 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of SLC19A1 mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO SLC19A1 (Homo sapiens) 6480464 Estradiol results in increased expression of SLC19A1 mRNA CTD PMID:23019147 and PMID:31614463 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Slc19a1 (Mus musculus) 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 Tetrachlorodibenzodioxin inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] CTD PMID:20451541 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc19a1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC19A1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Slc19a1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC19A1 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SLC19A1 mRNA and Tetrachlorodibenzodioxin results in decreased expression of SLC19A1 protein CTD PMID:20451541 2,3,7,8-tetrachlorodibenzodioxine decreases activity EXP 6480464 Tetrachlorodibenzodioxin results in decreased activity of SLC19A1 protein CTD PMID:20451541 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Slc19a1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SLC19A1 mRNA CTD PMID:17942748 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of SLC19A1 mRNA CTD PMID:21346803 2-palmitoylglycerol increases expression ISO SLC19A1 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of SLC19A1 mRNA CTD PMID:37199045 4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid multiple interactions ISO SLC19A1 (Homo sapiens) 6480464 [4 more ... CTD PMID:17034785 4-Acetamido-4'-isothiocyanostilbene-2,2'-disulphonic acid multiple interactions ISO SLC19A1 (Homo sapiens) 6480464 [4-Acetamido-4'-isothiocyanatostilbene-2 and 2'-disulfonic Acid results in decreased activity of SLC19A1 protein] which results in decreased uptake of Folic Acid CTD PMID:17034785 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of SLC19A1 mRNA CTD PMID:21346803 5,6,7,8-tetrahydrofolic acid multiple interactions EXP 6480464 5 more ... CTD PMID:14612385 5,6,7,8-tetrahydrofolic acid decreases activity EXP 6480464 5 more ... CTD PMID:14612385 5-aza-2'-deoxycytidine increases expression ISO SLC19A1 (Homo sapiens) 6480464 Decitabine results in increased expression of SLC19A1 mRNA CTD PMID:11509559 5-formyltetrahydrofolic acid multiple interactions ISO SLC19A1 (Homo sapiens) 6480464 Leucovorin inhibits the reaction [SLC19A1 protein results in increased transport of Methotrexate] CTD PMID:21879757 5-methyltetrahydrofolic acid multiple interactions ISO SLC19A1 (Homo sapiens) 6480464 [5-methyltetrahydrofolate results in decreased activity of SLC19A1 protein] which results in decreased uptake of Folic Acid CTD PMID:17034785 5-methyltetrahydrofolic acid decreases activity EXP 6480464 5-methyltetrahydrofolate results in decreased activity of SLC19A1 protein CTD PMID:14612385 5-methyltetrahydrofolic acid multiple interactions EXP 6480464 5-methyltetrahydrofolate inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] CTD PMID:14612385 acrylamide decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Acrylamide results in decreased expression of SLC19A1 mRNA CTD PMID:32763439 aflatoxin B1 increases methylation ISO SLC19A1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of SLC19A1 intron CTD PMID:30157460 alendronic acid affects expression EXP 6480464 Alendronate affects the expression of SLC19A1 mRNA CTD PMID:16079270 all-trans-retinoic acid decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Tretinoin results in decreased expression of SLC19A1 mRNA CTD PMID:23724009 and PMID:33167477 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC19A1 mRNA CTD PMID:16483693 antirheumatic drug increases response to substance ISO SLC19A1 (Homo sapiens) 6480464 SLC19A1 gene polymorphism results in increased susceptibility to Antirheumatic Agents CTD PMID:18322994 antirheumatic drug increases expression ISO SLC19A1 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of SLC19A1 mRNA CTD PMID:24449571 antirheumatic drug affects response to substance ISO SLC19A1 (Homo sapiens) 6480464 SLC19A1 protein affects the susceptibility to Antirheumatic Agents CTD PMID:18322994 aristolochic acid A decreases expression ISO SLC19A1 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of SLC19A1 mRNA and aristolochic acid I results in decreased expression of SLC19A1 protein CTD PMID:33212167 arsane affects methylation ISO SLC19A1 (Homo sapiens) 6480464 Arsenic affects the methylation of SLC19A1 gene CTD PMID:25304211 arsenic atom affects methylation ISO SLC19A1 (Homo sapiens) 6480464 Arsenic affects the methylation of SLC19A1 gene CTD PMID:25304211 atenolol decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Atenolol results in decreased expression of SLC19A1 mRNA CTD PMID:19616087 atrazine decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Atrazine results in decreased expression of SLC19A1 mRNA CTD PMID:22378314 benzo[a]pyrene affects methylation ISO SLC19A1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC19A1 promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO SLC19A1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SLC19A1 5' UTR CTD PMID:27901495 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC19A1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO SLC19A1 (Homo sapiens) 6480464 bisphenol A results in decreased expression of SLC19A1 mRNA and bisphenol A results in decreased expression of SLC19A1 protein CTD PMID:29275510 and PMID:33376534 bromosulfophthalein multiple interactions EXP 6480464 Sulfobromophthalein inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] CTD PMID:14612385 bromosulfophthalein decreases activity EXP 6480464 Sulfobromophthalein results in decreased activity of SLC19A1 protein CTD PMID:14612385 bumetanide multiple interactions EXP 6480464 Bumetanide inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] CTD PMID:14612385 bumetanide decreases activity EXP 6480464 Bumetanide results in decreased activity of SLC19A1 protein CTD PMID:14612385 caffeine affects phosphorylation ISO SLC19A1 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of SLC19A1 protein CTD PMID:35688186 calciol multiple interactions ISO Slc19a1 (Mus musculus) 6480464 Cholecalciferol inhibits the reaction [Lipopolysaccharides results in decreased expression of SLC19A1 mRNA] CTD PMID:25673501 carbamazepine decreases expression EXP 6480464 Carbamazepine results in decreased expression of SLC19A1 protein CTD PMID:21737571 carbamazepine affects expression ISO SLC19A1 (Homo sapiens) 6480464 Carbamazepine affects the expression of SLC19A1 mRNA CTD PMID:24752500 carbamazepine multiple interactions EXP 6480464 [Carbamazepine results in decreased expression of SLC19A1 protein] which results in decreased transport of Methotrexate and Carbamazepine inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] CTD PMID:17482559 and PMID:21737571 carbamazepine decreases activity EXP 6480464 Carbamazepine results in decreased activity of SLC19A1 protein CTD PMID:17482559 carbon nanotube increases expression ISO Slc19a1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 chlorpromazine multiple interactions EXP 6480464 Chlorpromazine inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] CTD PMID:17482559 chlorpromazine decreases activity EXP 6480464 Chlorpromazine results in decreased activity of SLC19A1 protein CTD PMID:17482559 cholate decreases activity EXP 6480464 Cholates results in decreased activity of SLC19A1 protein CTD PMID:14612385 cholate multiple interactions EXP 6480464 Cholates inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] CTD PMID:14612385 choline multiple interactions ISO Slc19a1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC19A1 gene CTD PMID:20938992 ciguatoxin CTX1B affects expression ISO Slc19a1 (Mus musculus) 6480464 Ciguatoxins affects the expression of SLC19A1 mRNA CTD PMID:18353800 cisplatin multiple interactions ISO SLC19A1 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SLC19A1 mRNA CTD PMID:27392435 clofibrate increases expression ISO Slc19a1 (Mus musculus) 6480464 Clofibrate results in increased expression of SLC19A1 mRNA CTD PMID:23811191 clotrimazole multiple interactions EXP 6480464 Clotrimazole inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] CTD PMID:17482559 clotrimazole decreases activity EXP 6480464 Clotrimazole results in decreased activity of SLC19A1 protein CTD PMID:17482559 cobalt dichloride decreases expression ISO SLC19A1 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of SLC19A1 mRNA CTD PMID:19320972 copper atom multiple interactions ISO SLC19A1 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of SLC19A1 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO SLC19A1 (Homo sapiens) 6480464 [NSC 689534 binds to Copper] which results in decreased expression of SLC19A1 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of SLC19A1 mRNA CTD PMID:19549813 coumarin decreases phosphorylation ISO SLC19A1 (Homo sapiens) 6480464 coumarin results in decreased phosphorylation of SLC19A1 protein CTD PMID:35688186 cyclosporin A increases expression ISO Slc19a1 (Mus musculus) 6480464 Cyclosporine results in increased expression of SLC19A1 mRNA CTD PMID:19770486 diazinon increases methylation ISO SLC19A1 (Homo sapiens) 6480464 Diazinon results in increased methylation of SLC19A1 gene CTD PMID:22964155 dibenzo[a,l]pyrene decreases expression ISO Slc19a1 (Mus musculus) 6480464 dibenzo(a and l)pyrene results in decreased expression of SLC19A1 mRNA CTD PMID:25908611 diclofenac affects expression ISO SLC19A1 (Homo sapiens) 6480464 Diclofenac affects the expression of SLC19A1 mRNA CTD PMID:24752500 dihydrofolic acid multiple interactions EXP 6480464 dihydrofolate inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] CTD PMID:14612385 dihydrofolic acid decreases activity EXP 6480464 dihydrofolate results in decreased activity of SLC19A1 protein CTD PMID:14612385 dioxygen decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Oxygen deficiency results in decreased expression of SLC19A1 mRNA CTD PMID:26516004 dioxygen multiple interactions ISO Slc19a1 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of SLC19A1 mRNA CTD PMID:30529165 diquat increases expression ISO Slc19a1 (Mus musculus) 6480464 Diquat results in increased expression of SLC19A1 mRNA CTD PMID:36851058 doxorubicin decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of SLC19A1 mRNA CTD PMID:29803840 elemental selenium decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Selenium results in decreased expression of SLC19A1 mRNA CTD PMID:19244175 epoxiconazole affects expression ISO Slc19a1 (Mus musculus) 6480464 epoxiconazole affects the expression of SLC19A1 mRNA CTD PMID:35436446 ethanol decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Ethanol results in decreased expression of SLC19A1 mRNA CTD PMID:19616087 ethanol increases expression EXP 6480464 Ethanol results in increased expression of SLC19A1 protein CTD PMID:17449590 ethyl methanesulfonate decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of SLC19A1 mRNA CTD PMID:23649840 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of SLC19A1 mRNA CTD PMID:23962444 flavonoids increases expression EXP 6480464 Flavonoids results in increased expression of SLC19A1 mRNA CTD PMID:18035473 folic acid multiple interactions ISO SLC19A1 (Homo sapiens) 6480464 [4 more ... CTD PMID:16750224 and PMID:17034785 folic acid decreases expression ISO Slc19a1 (Mus musculus) 6480464 Folic Acid results in decreased expression of SLC19A1 mRNA CTD PMID:25629700 folic acid affects abundance ISO SLC19A1 (Homo sapiens) 6480464 SLC19A1 gene SNP affects the abundance of Folic Acid CTD PMID:17325736 folic acid increases expression ISO SLC19A1 (Homo sapiens) 6480464 Folic Acid deficiency results in increased expression of SLC19A1 mRNA CTD PMID:18623116 folic acid multiple interactions ISO Slc19a1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC19A1 gene CTD PMID:20938992 folic acid affects uptake EXP 6480464 SLC19A1 protein affects the uptake of Folic Acid CTD PMID:16495369 folic acid increases uptake ISO SLC19A1 (Homo sapiens) 6480464 SLC19A1 protein results in increased uptake of Folic Acid CTD PMID:16900951 folic acid decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Folic Acid deficiency results in decreased expression of SLC19A1 mRNA more ... CTD PMID:17616776 more ... folic acid affects expression ISO SLC19A1 (Homo sapiens) 6480464 Folic Acid affects the expression of SLC19A1 mRNA CTD PMID:17311948 formaldehyde decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of SLC19A1 mRNA CTD PMID:23649840 FR900359 decreases phosphorylation ISO SLC19A1 (Homo sapiens) 6480464 FR900359 results in decreased phosphorylation of SLC19A1 protein CTD PMID:37730182 furan increases methylation EXP 6480464 furan results in increased methylation of SLC19A1 gene CTD PMID:22079235 genistein increases expression ISO SLC19A1 (Homo sapiens) 6480464 Genistein results in increased expression of SLC19A1 mRNA CTD PMID:23019147 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SLC19A1 mRNA CTD PMID:33387578 hydrogen peroxide affects expression ISO SLC19A1 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of SLC19A1 mRNA CTD PMID:20044591 ICI D1694 increases response to substance ISO SLC19A1 (Homo sapiens) 6480464 SLC19A1 protein results in increased susceptibility to raltitrexed CTD PMID:21879757 ICI D1694 decreases response to substance ISO SLC19A1 (Homo sapiens) 6480464 SLC19A1 exon mutant form results in decreased susceptibility to raltitrexed CTD PMID:16505119 ICI D1694 multiple interactions ISO SLC19A1 (Homo sapiens) 6480464 raltitrexed inhibits the reaction [SLC19A1 protein results in increased transport of Methotrexate] CTD PMID:21879757 indometacin multiple interactions ISO SLC19A1 (Homo sapiens) 6480464 [Indomethacin results in decreased activity of SLC19A1 protein] which results in decreased uptake of Folic Acid CTD PMID:17034785 inulin multiple interactions ISO Slc19a1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SLC19A1 mRNA CTD PMID:36331819 irinotecan decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Irinotecan analog results in decreased expression of SLC19A1 mRNA CTD PMID:18927307 L-methionine multiple interactions ISO Slc19a1 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SLC19A1 gene CTD PMID:20938992 Lasiocarpine multiple interactions ISO SLC19A1 (Homo sapiens) 6480464 [CYP3A4 protein results in increased metabolism of lasiocarpine] which results in decreased expression of SLC19A1 mRNA CTD PMID:33884520 lipopolysaccharide multiple interactions ISO Slc19a1 (Mus musculus) 6480464 Cholecalciferol inhibits the reaction [Lipopolysaccharides results in decreased expression of SLC19A1 mRNA] CTD PMID:25673501 lipopolysaccharide decreases expression ISO Slc19a1 (Mus musculus) 6480464 Lipopolysaccharides results in decreased expression of SLC19A1 mRNA CTD PMID:25673501 methotrexate increases response to substance ISO SLC19A1 (Homo sapiens) 6480464 SLC19A1 gene SNP results in increased susceptibility to Methotrexate more ... CTD PMID:11509559 more ... methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of SLC19A1 mRNA CTD PMID:30502384 methotrexate increases expression ISO Slc19a1 (Mus musculus) 6480464 Methotrexate results in increased expression of SLC19A1 mRNA CTD PMID:30502384 methotrexate decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Methotrexate results in decreased expression of SLC19A1 mRNA and Methotrexate results in decreased expression of SLC19A1 protein CTD PMID:24736981 and PMID:25078587 methotrexate affects expression ISO SLC19A1 (Homo sapiens) 6480464 Methotrexate affects the expression of SLC19A1 mRNA CTD PMID:23838799 methotrexate affects transport ISO SLC19A1 (Homo sapiens) 6480464 SLC19A1 3' UTR polymorphism affects the transport of Methotrexate CTD PMID:24927955 methotrexate increases transport ISO SLC19A1 (Homo sapiens) 6480464 SLC19A1 protein results in increased transport of Methotrexate CTD PMID:11509559 and PMID:21879757 methotrexate increases uptake EXP 6480464 SLC19A1 protein results in increased uptake of Methotrexate CTD PMID:17482559 more ... methotrexate affects transport EXP 6480464 SLC19A1 protein affects the transport of Methotrexate CTD PMID:14612385 methotrexate increases response to substance EXP 6480464 SLC19A1 protein results in increased susceptibility to Methotrexate CTD PMID:14612385 methotrexate decreases activity EXP 6480464 Methotrexate results in decreased activity of SLC19A1 protein CTD PMID:14612385 methotrexate multiple interactions EXP 6480464 1 more ... CTD PMID:14612385 more ... methotrexate increases response to substance ISO Slc19a1 (Mus musculus) 6480464 SLC19A1 protein results in increased susceptibility to Methotrexate CTD PMID:12396629 methotrexate affects response to substance ISO SLC19A1 (Homo sapiens) 6480464 SLC19A1 gene SNP affects the susceptibility to Methotrexate and SLC19A1 protein affects the susceptibility to Methotrexate CTD PMID:14679136 more ... methotrexate decreases response to substance ISO SLC19A1 (Homo sapiens) 6480464 SLC19A1 exon mutant form results in decreased susceptibility to Methotrexate CTD PMID:16505119 methotrexate multiple interactions ISO SLC19A1 (Homo sapiens) 6480464 [Methotrexate results in decreased activity of SLC19A1 protein] which results in decreased uptake of Folic Acid more ... CTD PMID:17034785 more ... methyl methanesulfonate decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of SLC19A1 mRNA CTD PMID:23649840 methylseleninic acid decreases expression ISO SLC19A1 (Homo sapiens) 6480464 methylselenic acid results in decreased expression of SLC19A1 mRNA CTD PMID:18548127 monocrotaline multiple interactions ISO SLC19A1 (Homo sapiens) 6480464 [CYP3A4 protein results in increased metabolism of Monocrotaline] which results in decreased expression of SLC19A1 mRNA CTD PMID:33884520 nicotine decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Nicotine results in decreased expression of SLC19A1 mRNA CTD PMID:19616087 okadaic acid multiple interactions EXP 6480464 Okadaic Acid inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] CTD PMID:17482559 okadaic acid decreases activity EXP 6480464 Okadaic Acid results in decreased activity of SLC19A1 protein CTD PMID:17482559 ozone multiple interactions ISO SLC19A1 (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of SLC19A1 mRNA CTD PMID:35430440 paracetamol affects expression ISO Slc19a1 (Mus musculus) 6480464 Acetaminophen affects the expression of SLC19A1 mRNA CTD PMID:17562736 paracetamol decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SLC19A1 mRNA CTD PMID:29067470 pemetrexed increases response to substance ISO SLC19A1 (Homo sapiens) 6480464 SLC19A1 exon mutant form results in increased susceptibility to Pemetrexed CTD PMID:16505119 pemetrexed multiple interactions ISO SLC19A1 (Homo sapiens) 6480464 Pemetrexed inhibits the reaction [SLC19A1 protein results in increased transport of Methotrexate] CTD PMID:21879757 perfluorooctane-1-sulfonic acid multiple interactions ISO Slc19a1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC19A1 mRNA more ... CTD PMID:36331819 phenobarbital decreases activity EXP 6480464 Phenobarbital results in decreased activity of SLC19A1 protein CTD PMID:17482559 phenobarbital multiple interactions EXP 6480464 [Phenobarbital results in decreased expression of SLC19A1 protein] which results in decreased transport of Methotrexate more ... CTD PMID:17482559 and PMID:21737571 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of SLC19A1 protein CTD PMID:21737571 phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 bisindolylmaleimide inhibits the reaction [Tetradecanoylphorbol Acetate inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate]] and Tetradecanoylphorbol Acetate inhibits the reaction [SLC19A1 protein results in increased uptake of Methotrexate] CTD PMID:17482559 phorbol 13-acetate 12-myristate decreases activity EXP 6480464 Tetradecanoylphorbol Acetate results in decreased activity of SLC19A1 protein CTD PMID:17482559 potassium chromate increases expression ISO SLC19A1 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of SLC19A1 mRNA CTD PMID:22714537 pregnenolone 16alpha-carbonitrile increases expression ISO Slc19a1 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of SLC19A1 mRNA CTD PMID:28903501 raloxifene affects expression EXP 6480464 Raloxifene Hydrochloride affects the expression of SLC19A1 mRNA CTD PMID:16079270 resveratrol multiple interactions ISO SLC19A1 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of SLC19A1 mRNA CTD PMID:23557933 S-adenosyl-L-homocysteine affects abundance ISO Slc19a1 (Mus musculus) 6480464 SLC19A1 protein affects the abundance of S-Adenosylhomocysteine CTD PMID:15705887 S-adenosyl-L-methioninate affects abundance ISO Slc19a1 (Mus musculus) 6480464 SLC19A1 protein affects the abundance of S-Adenosylmethionine CTD PMID:15705887 S-adenosyl-L-methionine affects abundance ISO Slc19a1 (Mus musculus) 6480464 SLC19A1 protein affects the abundance of S-Adenosylmethionine CTD PMID:15705887 selenium atom decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Selenium results in decreased expression of SLC19A1 mRNA CTD PMID:19244175 taurocholic acid multiple interactions EXP 6480464 Taurocholic Acid inhibits the reaction [SLC19A1 protein affects the transport of Methotrexate] CTD PMID:14612385 taurocholic acid decreases activity EXP 6480464 Taurocholic Acid results in decreased activity of SLC19A1 protein CTD PMID:14612385 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC19A1 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO SLC19A1 (Homo sapiens) 6480464 trichostatin A results in decreased expression of SLC19A1 mRNA CTD PMID:28542535 trimellitic anhydride increases expression ISO Slc19a1 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of SLC19A1 mRNA CTD PMID:19042947 trimetrexate decreases response to substance ISO Slc19a1 (Mus musculus) 6480464 SLC19A1 protein results in decreased susceptibility to Trimetrexate CTD PMID:12396629 troglitazone increases expression ISO Slc19a1 (Mus musculus) 6480464 troglitazone results in increased expression of SLC19A1 mRNA CTD PMID:28973697 urethane decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Urethane results in decreased expression of SLC19A1 mRNA CTD PMID:28818685 valproic acid increases methylation ISO SLC19A1 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of SLC19A1 gene CTD PMID:29154799 vitamin E decreases expression ISO SLC19A1 (Homo sapiens) 6480464 Vitamin E results in decreased expression of SLC19A1 mRNA CTD PMID:19244175